Sale!

Immunohistochemistry Ki-67 Test Cost

Original price was: 550 د.إ.Current price is: 500 د.إ.

-9%

The Immunohistochemistry Ki-67 test is a specialized diagnostic tool used to measure the proliferation rate of cells in various types of tissue, most commonly in tumors. By staining tissue samples with a specific antibody that targets the Ki-67 protein, a marker present in the nucleus of dividing cells, this test helps in assessing the growth fraction of a given cell population. The presence and level of Ki-67 protein can be indicative of the aggressiveness of cancer, guiding treatment decisions and prognostication.

At DNA Labs UAE, the Ki-67 test is offered for a cost of 500 AED. The lab utilizes state-of-the-art immunohistochemistry techniques to provide accurate and reliable results, aiding in the diagnosis and management of patients with cancer. By evaluating the proportion of Ki-67 positive cells, oncologists and pathologists can gain valuable insights into the biological behavior of the tumor, which is crucial for optimizing patient care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY Ki-67 Test

Test Name: IMMUNOHISTOCHEMISTRY Ki-67 Test

Components: Ki-67 protein

Price: 500.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days

Method: Immunohistochemistry

Test Type: Cancer

Doctor: Oncologist, Pathologist

Test Department:

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details:

The Ki-67 test is an immunohistochemistry (IHC) test used to measure the level of Ki-67 protein in cells. Ki-67 is a nuclear protein that is expressed during active phases of the cell cycle, specifically in the G1, S, G2, and M phases. It is commonly used as a marker for cellular proliferation.

In the Ki-67 test, tissue samples are collected and processed into thin sections, which are then placed on slides. The slides are then treated with specific antibodies that bind to the Ki-67 protein. These antibodies are labeled with a dye or enzyme that produces a visible signal when the antibody binds to the protein.

After the antibody treatment, the slides are examined under a microscope, and the percentage of cells that are positive for Ki-67 staining is determined. This percentage, known as the Ki-67 labeling index, reflects the proportion of cells in the active phases of the cell cycle.

The Ki-67 test is commonly used in cancer research and clinical practice to assess the proliferation rate of tumor cells. It can provide important information about the aggressiveness of a tumor and help guide treatment decisions. High Ki-67 labeling index is often associated with a poorer prognosis and increased likelihood of tumor recurrence.

Overall, the Ki-67 test is a valuable tool in immunohistochemistry that provides insights into the proliferative activity of cells and can aid in the diagnosis and management of various diseases, particularly cancer.

Test Name IMMUNOHISTOCHEMISTRY Ki-67 Test
Components
Price 500.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department:
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The Ki-67 test is an immunohistochemistry (IHC) test used to measure the level of Ki-67 protein in cells. Ki-67 is a nuclear protein that is expressed during active phases of the cell cycle, specifically in the G1, S, G2, and M phases. It is commonly used as a marker for cellular proliferation.

In the Ki-67 test, tissue samples are collected and processed into thin sections, which are then placed on slides. The slides are then treated with specific antibodies that bind to the Ki-67 protein. These antibodies are labeled with a dye or enzyme that produces a visible signal when the antibody binds to the protein.

After the antibody treatment, the slides are examined under a microscope, and the percentage of cells that are positive for Ki-67 staining is determined. This percentage, known as the Ki-67 labeling index, reflects the proportion of cells in the active phases of the cell cycle.

The Ki-67 test is commonly used in cancer research and clinical practice to assess the proliferation rate of tumor cells. It can provide important information about the aggressiveness of a tumor and help guide treatment decisions. High Ki-67 labeling index is often associated with a poorer prognosis and increased likelihood of tumor recurrence.

Overall, the Ki-67 test is a valuable tool in immunohistochemistry that provides insights into the proliferative activity of cells and can aid in the diagnosis and management of various diseases, particularly cancer.